• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    2/9/22 10:01:24 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No. 8 UNITEDHEALTH GROUP INC COMMON STOCK Cusip #91324P102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #91324P102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 7,158,989 Item 6: 0 Item 7: 48,646,794 Item 8: 0 Item 9: 48,646,794 Item 11: 5.165% Item 12: HC Cusip #91324P102 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 48,646,794 Item 8: 0 Item 9: 48,646,794 Item 11: 5.165% Item 12: IN Item 1(a). Name of Issuer: UNITEDHEALTH GROUP INC Item 1(b). Address of Issuer's Principal Executive Offices: UnitedHealth Group Center, 9900 Bren Road East Minneapolis, MN 55343 Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 91324P102 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 48,646,794 (b) Percent of Class: 5.165% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 7,158,989 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 48,646,794 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of UNITEDHEALTH GROUP INC. No one other person's interest in the COMMON STOCK of UNITEDHEALTH GROUP INC is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2022 Date /s/ Kevin M. Meagher Signature Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Crosby Advisors LLC N/A FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC IA Fidelity Management Trust Company BK FMR Investment Management (UK) Limited FI Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company LLC ("FMR Co. LLC"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2022, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of UNITEDHEALTH GROUP INC at December 31, 2021. FMR LLC By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 30, 2018, by and on behalf of Abigail P. Johnson* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414.
    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $UNH
    SEC Filings

    See more
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/18/25 5:00:15 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form FWP filed by UnitedHealth Group Incorporated

      FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      6/17/25 5:23:28 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/17/25 8:45:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer, Optum Conway Patrick Hugh sold $179,645 worth of shares (589 units at $305.00), decreasing direct ownership by 5% to 10,398 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/12/25 5:13:18 PM ET
      $UNH
      Medical Specialities
      Health Care
    • EVP & Chief People Officer Mcsweeney Erin covered exercise/tax liability with 130 shares, decreasing direct ownership by 1% to 11,076 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/9/25 4:49:53 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 828 shares, decreasing direct ownership by 7% to 10,987 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/9/25 4:49:31 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00

      6/11/25 7:46:38 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

      UnitedHealth Group (NYSE:UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. At its regular quarterly meeting, the Boa

      6/4/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Earnings Release Date

      UnitedHealth Group (NYSE:UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through August 12 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by te

      6/2/25 4:15:00 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Financials

    Live finance-specific insights

    See more
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

      UnitedHealth Group (NYSE:UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. At its regular quarterly meeting, the Boa

      6/4/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Leadership Transition

      Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Company expects to return to growth in 2026 UnitedHealth Group (NYSE:UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty's decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company's Board of Directors and Witty will serve as a senior adviser to Hemsley. "We are grateful for Andrew's stewardship of UnitedHealth Group, especially during some of the most challenging times any company

      5/13/25 6:30:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care